Skip to main content

Security report for sanofigenzyme.com

Sanofi · Healthcare · France

Medium risk. 7 critical or high findings in GDPR outside view, SSL/TLS and 1 other check.

Security score

54/100

Risk levelMedium

0–100, higher is better. How it is calculated

Sanofi is a leading global healthcare and pharmaceutical company specializing in innovative medicines across specialty and general medicine areas. The website reflects a mature enterprise with comprehensive content targeting patients, healthcare professionals, investors, and partners. The technical infrastructure leverages modern web technologies including React and Material-UI, hosted on AWS CloudFront with Magnolia CMS. Privacy and cookie policies are well implemented with GDPR compliance, and the site integrates marketing and analytics tools such as Google Tag Manager and OneTrust. However, a critical security gap exists due to the absence of a valid SSL certificate and lack of TLS protocol support, significantly impacting the security posture. This exposes users to potential risks and undermines trust despite strong content and business credibility. Strategic remediation of SSL/TLS and related security configurations is essential to align the website with industry best practices and regulatory requirements.

Scanned

NIS2 and GDPR posture

GDPR outside view
0/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

Need hands-on remediation? Email guard@offseq.com

Keep watching sanofigenzyme.com

This scan found 17 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
85
Email security
70
DNS health
70
Network security
100
GDPR outside view
0
Average
54

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Sanofi operates as a large multinational enterprise in the healthcare sector, offering a broad portfolio of specialty and general medicines, vaccines, and clinical trial services. The company maintains a strong global presence with localized sites and a robust partnering ecosystem. The business model focuses on pharmaceutical R&D, manufacturing, and distribution, supported by extensive digital engagement and investor relations. The website's content and navigation demonstrate a clear focus on multiple stakeholder groups, including patients and healthcare professionals, enhancing market reach and engagement. The presence of a consumer healthcare subsidiary (Opella) indicates diversification within the healthcare domain. Overall, Sanofi's market positioning is strong, supported by consistent branding and comprehensive service offerings.

Security posture

The website implements several security headers such as Content Security Policy, XSS Protection, and frame options, indicating awareness of security best practices. However, the absence of a valid SSL certificate and lack of support for TLS protocols represent critical vulnerabilities that severely degrade the security posture. The missing HSTS enforcement and OCSP stapling further weaken the site's defense against man-in-the-middle attacks and certificate-related issues. No incident response or security policy information is publicly available, which may impact transparency and readiness. While no exposed sensitive data or vulnerable libraries were detected, the SSL/TLS deficiencies pose significant risks to user data confidentiality and integrity.

Recommendations

  1. Urgently install and maintain a valid SSL/TLS certificate supporting modern protocols (TLS 1.2 or 1.3).
  2. Enable HTTP Strict Transport Security (HSTS) with includeSubDomains and preload directives.
  3. Implement OCSP stapling to improve certificate revocation checking and performance.
  4. Publish a clear security policy and incident response contact information to enhance transparency.
  5. Regularly audit security headers and update configurations to maintain best practices.
Technical notes

Notes

The website is built using modern front-end technologies including React and Material-UI, providing a responsive and accessible user experience. Hosting is via AWS CloudFront CDN, ensuring global content delivery. The CMS platform is Magnolia, which supports enterprise content management needs. Analytics and marketing tools such as Google Tag Manager, OneTrust, and LaunchDarkly are integrated for tracking, consent management, and feature flagging. Despite these strengths, the lack of SSL/TLS support is a major technical deficiency. Performance metrics were not available, but the use of CDN and modern frameworks suggests potential for good performance. Accessibility and SEO optimizations appear well implemented based on meta tags and ARIA attributes.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with sanofigenzyme.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review sanofigenzyme.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.